TABLE OF CONTENTS
1 INTRODUCTION 33
1.1 OBJECTIVES OF THE STUDY 33
1.2 MARKET DEFINITION 33
1.3 OVERVIEW OF EUROPE AMINO ACID IN DIETARY SUPPLEMENTS MARKET 33
1.4 LIMITATIONS 35
1.5 MARKETS COVERED 35
2 MARKET SEGMENTATION 37
2.1 MARKETS COVERED 37
2.2 GEOGRAPHICAL SCOPE 38
2.3 YEARS CONSIDERED FOR THE STUDY 39
2.4 CURRENCY AND PRICING 39
2.5 DBMR TRIPOD DATA VALIDATION MODEL 40
2.6 MULTIVARIATE MODELLING 43
2.7 PRODUCT LIFELINE CURVE 43
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 44
2.9 DBMR MARKET POSITION GRID 45
2.10 MARKET APPLICATION COVERAGE GRID 46
2.11 SECONDARY SOURCES 47
2.12 ASSUMPTIONS 47
3 EXECUTIVE SUMMARY 48
4 PREMIUM INSIGHTS 50
4.1 PORTER'S FIVE FORCES 51
4.1.1 THE THREAT OF NEW ENTRANTS 51
4.1.2 THE THREAT OF SUBSTITUTES 52
4.1.3 CUSTOMER BARGAINING POWER 53
4.1.4 SUPPLIER BARGAINING POWER 53
4.1.5 INTERNAL COMPETITION (RIVALRY) 54
4.2 CONSUMER LEVEL TRENDS OF EUROPE AMINO ACID IN DIETARY SUPPLEMENTS MARKET 55
4.2.1 OVERVIEW 55
4.2.2 HEALTH BENEFITS FROM AMINO ACIDS-BASED DIETARY SUPPLEMENTS 55
4.2.3 CERTIFIED AND RELIABLE PRODUCTS 56
4.2.4 ON-THE-GO FOOD PRODUCTS 56
4.3 FACTOR INFLUENCING PURCHASE DECISION 57
4.3.1 HIGH NUTRITIONAL VALUE 57
4.3.2 PRICING OF THE AMINO ACIDS 57
4.3.3 HIGH QUALITY 58
4.4 GROWTH STRATEGIES ADOPTED BY KEY MARKET PLAYERS 59
4.5 IMPACT OF ECONOMIC SLOWDOWN ON THE MARKET 60
4.5.1 IMPACT OF COVID-19 60
4.5.2 IMPACT OF WAR 60
4.5.3 IMPACT ON SUPPLY CHAIN 61
4.6 INDUSTRY TRENDS AND FUTURE PERSPECTIVE 62
4.6.1 RISING ADOPTION OF ADVANCED TECHNOLOGIES AND NEW BENEFICIAL FORMULATIONS IN NEW PRODUCT DEVELOPMENT OF AMINO ACIDS IN THE DIETARY SUPPLEMENT INDUSTRY 62
4.6.2 CERTIFICATIONS & LABELLING CLAIMS AMONG MANUFACTURERS 63
4.6.3 BUSINESS EXPANSIONS THROUGH DIFFERENT STRATEGIC DECISIONS 63
4.6.4 FUTURE PERSPECTIVE 64
5 SUPPLY CHAIN ANALYSIS 65
5.1 RAW MATERIAL PROCUREMENT 66
5.2 PROCESSING AND MANUFACTURING 66
5.3 MARKETING AND DISTRIBUTION 66
5.4 END USERS 67
6 VALUE CHAIN ANALYSIS 68
7 REGULATORY FRAMEWORK AND GUIDELINES 70
8 MARKET OVERVIEW 73
8.1 DRIVERS 75
8.1.1 INCREASING DEMAND FOR AMINO ACID-BASED DIETARY SUPPLEMENTS DUE TO THE HEALTH AND NUTRITIONAL BENEFITS 75
8.1.2 RISING BIOTECHNOLOGICAL ADVANCEMENT IN AMINO ACID PRODUCTION FOR DIETARY SUPPLEMENTS 75
8.1.3 INCREASING LAUNCHES OF AMINO ACID-BASED DIETARY SUPPLEMENTS IN THE MARKET 76
8.1.4 GROWING A SUSTAINABLE AND WELL-ESTABLISHED SUPPLY CHAIN IN THE MARKET 77
8.2 RESTRAINTS 78
8.2.1 AVAILABILITY OF SUBSTITUTES FOR AMINO ACID-BASED DIETARY SUPPLEMENTS 78
8.2.2 STRINGENT GOVERNMENT REGULATIONS 78
8.3 OPPORTUNITIES 79
8.3.1 RISING AWARENESS AMONG CONSUMERS TOWARDS CONSUMPTION OF AMINO ACID-BASED DIETARY SUPPLEMENTS 79
8.3.2 INCREASING BUSINESS ACTIVITIES AND INVESTMENTS DONE BY THE DIETARY SUPPLEMENTS PRODUCERS IN THE MARKET 80
8.4 CHALLENGES 80
8.4.1 COMPLEX MANUFACTURING PROCESS 80
8.4.2 RISING AWARENESS REGARDING THE SIDE EFFECTS CAUSED BY OVERCONSUMPTION OF AMINO ACID 81
8.4.3 INCREASING R&D ON PERSONALIZED NUTRITION 82
9 EUROPE AMINO ACID IN DIETARY SUPPLEMENTS MARKET, BY TYPE 83
9.1 OVERVIEW 84
9.2 GLUTAMIC ACID 85
9.3 METHIONINE 87
9.4 LYSINE 88
9.5 PHENYLALANINE 89
9.6 TRYPTOPHAN 90
9.7 OTHERS 91
10 EUROPE AMINO ACID IN DIETARY SUPPLEMENTS MARKET, BY FORM 93
10.1 OVERVIEW 94
10.2 POWDERS 95
10.3 LIQUIDS 97
10.4 SOFT GELS 98
10.5 TABLETS 99
10.6 CAPSULES 100
10.7 GUMMIES 101
10.8 OTHERS 102
11 EUROPE AMINO ACID IN DIETARY SUPPLEMENTS MARKET, BY APPLICATION 104
11.1 OVERVIEW 105
11.2 ENERGY & WEIGHT MANAGEMENT 107
11.3 IMMUNITY 108
11.4 GENERAL HEALTH 109
11.5 BONE & JOINT HEALTH 111
11.6 DIABETES 112
11.7 GASTROINTESTINAL HEALTH 113
11.8 CARDIAC HEALTH 114
11.9 ANTI-CANCER 115
11.10 OTHERS 116
12 EUROPE AMINO ACID IN DIETARY SUPPLEMENTS MARKET, BY END USER 118
12.1 OVERVIEW 119
12.2 ADULTS 120
12.3 GERIATRIC 122
12.4 PREGNANT WOMEN 123
12.5 CHILDREN 124
12.6 INFANTS 125
13 EUROPE AMINO ACID IN DIETARY SUPPLEMENTS MARKET, BY DISTRIBUTION CHANNEL 127
13.1 OVERVIEW 128
13.2 OTC 129
13.3 PRESCRIBED 130
14 EUROPE AMINO ACID IN DIETARY SUPPLEMENTS MARKET, BY REGION 132
14.1 EUROPE 133
14.1.1 GERMANY 143
14.1.2 SPAIN 147
14.1.3 FRANCE 151
14.1.4 ITALY 155
14.1.5 U.K. 159
14.1.6 NETHERLANDS 163
14.1.7 BELGIUM 167
14.1.8 SWITZERLAND 171
14.1.9 RUSSIA 175
14.1.10 TURKEY 179
14.1.11 REST OF EUROPE 183
15 COMPANY LANDSCAPE 184
15.1 COMPANY SHARE ANALYSIS: EUROPE 184
16 SWOT ANALYSIS 185
17 COMPANY PROFILES 186
17.1 EVONIK INDUSTRIES AG 186
17.1.1 COMPANY SNAPSHOT 186
17.1.2 REVENUE ANALYSIS 186
17.1.3 COMPANY SHARE ANALYSIS 187
17.1.4 PRODUCT PORTFOLIO 187
17.1.5 RECENT DEVELOPMENTS 188
17.2 AJINOMOTO CO., INC. 189
17.2.1 COMPANY SNAPSHOT 189
17.2.2 REVENUE ANALYSIS 189
17.2.3 COMPANY SHARE ANALYSIS 190
17.2.4 PRODUCT PORTFOLIO 190
17.2.5 RECENT DEVELOPMENTS 191
17.3 NOW FOODS 192
17.3.1 COMPANY SNAPSHOT 192
17.3.2 COMPANY SHARE ANALYSIS 192
17.3.3 PRODUCT PORTFOLIO 193
17.3.4 RECENT DEVELOPMENTS 193
17.4 MUSCLEPHARM 194
17.4.1 COMPANY SNAPSHOT 194
17.4.2 REVENUE ANALYSIS 194
17.4.3 COMPANY SHARE ANALYSIS 195
17.4.4 PRODUCT PORTFOLIO 195
17.4.5 RECENT DEVELOPMENTS 195
17.5 JARROW FORMULAS, INC 196
17.5.1 COMPANY SNAPSHOT 196
17.5.2 COMPANY SHARE ANALYSIS 196
17.5.3 PRODUCT PORTFOLIO 197
17.5.4 RECENT DEVELOPMENTS 197
17.6 ALLMAX 198
17.6.1 COMPANY SNAPSHOT 198
17.6.2 PRODUCT PORTFOLIO 198
17.6.3 RECENT DEVELOPMENTS 198
17.7 BEVERLY INTERNATIONAL 199
17.7.1 COMPANY SNAPSHOT 199
17.7.2 PRODUCT PORTFOLIO 199
17.7.3 RECENT DEVELOPMENT 199
17.8 BIOVEA 200
17.8.1 COMPANY SNAPSHOT 200
17.8.2 PRODUCT PORTFOLIO 200
17.8.3 RECENT DEVELOPMENTS 200
17.9 CELLUCOR 201
17.9.1 COMPANY SNAPSHOT 201
17.9.2 PRODUCT PORTFOLIO 201
17.9.3 RECENT DEVELOPMENTS 201
17.10 EVLUTION NUTRITION 202
17.10.1 COMPANY SNAPSHOT 202
17.10.2 PRODUCT PORTFOLIO 202
17.10.3 RECENT DEVELOPMENTS 202
17.11 FIVE PERCENT NUTRITION, LLC. 203
17.11.1 COMPANY SNAPSHOT 203
17.11.2 PRODUCT PORTFOLIO 203
17.11.3 RECENT DEVELOPMENTS 203
17.12 GAT WHP 204
17.12.1 COMPANY SNAPSHOT 204
17.12.2 PRODUCT PORTFOLIO 204
17.12.3 RECENT DEVELOPMENTS 205
17.13 KAGED 206
17.13.1 COMPANY SNAPSHOT 206
17.13.2 PRODUCT PORTFOLIO 206
17.13.3 RECENT DEVELOPMENT 206
17.14 NUTRABIO LABS, INC. 207
17.14.1 COMPANY SNAPSHOT 207
17.14.2 PRODUCT PORTFOLIO 207
17.14.3 RECENT DEVELOPMENTS 207
17.15 OPTIMUM NUTRITION 208
17.15.1 COMPANY SNAPSHOT 208
17.15.2 PRODUCT PORTFOLIO 208
17.15.3 RECENT DEVELOPMENT 209
17.16 PROSUPPS USA, LLC 210
17.16.1 COMPANY SNAPSHOT 210
17.16.2 PRODUCT PORTFOLIO 210
17.16.3 RECENT DEVELOPMENT 211
17.17 RELIANCE PRIVATE LABEL SUPPLEMENTS 212
17.17.1 COMPANY SNAPSHOT 212
17.17.2 PRODUCT PORTFOLIO 212
17.17.3 RECENT DEVELOPMENTS 212
17.18 SOLGAR INC. 213
17.18.1 COMPANY SNAPSHOT 213
17.18.2 PRODUCT PORTFOLIO 213
17.18.3 RECENT DEVELOPMENT 214
17.19 TRUE NUTRITION 215
17.19.1 COMPANY SNAPSHOT 215
17.19.2 PRODUCT PORTFOLIO 215
17.19.3 RECENT DEVELOPMENTS 215
17.20 UNIVERSAL NUTRITION 216
17.20.1 COMPANY SNAPSHOT 216
17.20.2 PRODUCT PORTFOLIO 216
17.20.3 RECENT DEVELOPMENTS 216
18 QUESTIONNAIRE 217
19 RELATED REPORTS 220

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.